Held in conjunction with the American Diabetes Association’s 2026 Scientific Sessions
Saturday, June 6, 2026
5:30 AM – 5:45 AM CT Registration & Breakfast
5:45 AM – 7:15 AM CT CE Symposium
Hilton New Orleans Riverside
Two Poydras Street
New Orleans, Louisiana 70130
Meeting Room: Grand Ballroom CD
PROGRAM FEATURES
-
- Clinical Community Exchange
- Find My Clinical TrialTM
- Create-your-own personalized poster
PRESENTING FACULTY
 |
John E. Anderson, MD Internal Medicine and Diabetes The Frist Clinic Nashville, Tennessee |
 |
Yehuda Handelsman, MD, FNLA, FACP, MACE Medical Director & Principal Investigator Metabolic Institute of America Tarzana, California |
PROGRAM OVERVIEW
This clinical conversation symposium offers a dynamic forum for healthcare professionals to exchange insights and tackle real-world challenges in the management of chronic kidney disease (CKD) and heart failure (HF). Guided by expert faculty, participants will engage in case-based discussions that bring current guidelines and emerging evidence to life.
The program explores practical approaches to improving early identification, refining treatment strategies to achieve cardiorenal benefits, and integrating shared decision-making (SDM) into everyday practice. Collaborative care will be a central theme, with discussion focused on how multidisciplinary teams (MDTs) can work together to deliver coordinated, patient-centered treatment plans.
LEARNING OBJECTIVES:
After completing the CME activity, learners should be better able to:
- Apply guideline recommendations and CMD pathophysiology to aid in the screening, diagnosis, and specialty referral for patients with CKD and/or HF.
- Employ the latest clinical evidence and guideline recommendations to create comprehensive treatment plans that provide cardiorenal benefits for patients with CKD and/or HF.
- Practice SDM to incorporate the patient’s perspective in therapy decisions and collaborate with the patient’s MDT to create a comprehensive therapy plan when treating patients with CKD and/or HF.
TARGET AUDIENCE
This educational activity is designed to meet the needs of healthcare providers in primary care, including general/family physicians and/or internal medicine physicians (PCPs), primary care advanced practice providers (APPs; e.g., nurse practitioners and physician’s assistants), and endocrinologists who play a crucial role in diagnosing and treating patients with chronic kidney disease (CKD) and heart failure (HF) as a result of cardio-renal metabolic disease (CMD). This activity is also designed to provide education on the optimal care of CKD and HF through the multidisciplinary team (MDT), as well as evidence-based treatment approaches.
JOINT ACCREDITATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 1.5 ANCC contact hours.
ACCME INNOVATION PARTNER
Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.
PHYSICIAN DISCLAIMER: Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at [email protected]
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group prior to the live event at [email protected]
